title: Emerging therapies for the treatment of neovascular age related macular degeneration.
abstract: Numerous drugs that show promise in the treatment of neovascular age related macular degeneration are currently being evaluated in early clinical trials. Some of these drugs target the vascular endothelial growth factor pathway while others act on different targets along the angiogenesis cascade. The mechanism of action of these novel therapeutics and the results of early clinical trials will be discussed along with a review of angiogenesis.
authors: Cole Eye Institute, Cleveland, OH 44195, USA.
authors: Alex
authors: A
authors: Yuan
authors: Peter K
authors: PK
authors: Kaiser